Multiple Extrathymic Precursors Contribute to T-cell Development with Different Kinetics
Overview
Authors
Affiliations
T-cell development in the thymus depends on continuous supply of T-cell progenitors from bone marrow (BM). Several extrathymic candidate progenitors have been described that range from multipotent cells to lymphoid cell committed progenitors and even largely T-lineage committed precursors. However, the nature of precursors seeding the thymus under physiologic conditions has remained largely elusive and it is not known whether there is only one physiologic T-cell precursor population or many. Here, we used a competitive in vivo assay based on depletion rather than enrichment of classes of BM-derived precursor populations, thereby only minimally altering physiologic precursor ratios to assess the contribution of various extrathymic precursors to T-lineage differentiation. We found that under these conditions multiple precursors, belonging to both multipotent progenitor (MPP) and common lymphoid progenitor (CLP) subsets have robust T-lineage potential. However, differentiation kinetics of different precursors varied considerably, which might ensure continuous thymic output despite gated importation of extrathymic precursors. In conclusion, our data suggest that the thymus functions to impose T-cell fate on any precursor capable of filling the limited number of progenitor niches.
WBP1L regulates hematopoietic stem cell function and T cell development.
Krayem I, Grusanovic S, Duric I, Pavliuchenko N, Danek P, Borna S Front Immunol. 2024; 15:1421512.
PMID: 39555063 PMC: 11563793. DOI: 10.3389/fimmu.2024.1421512.
Transcriptional network dynamics in early T cell development.
Shin B, Chang S, MacNabb B, Rothenberg E J Exp Med. 2024; 221(10).
PMID: 39167073 PMC: 11338287. DOI: 10.1084/jem.20230893.
Shin B, Rothenberg E Front Immunol. 2023; 14:1108368.
PMID: 36817475 PMC: 9928580. DOI: 10.3389/fimmu.2023.1108368.
Speed and navigation control of thymocyte development by the fetal T-cell gene regulatory network.
MacNabb B, Rothenberg E Immunol Rev. 2023; 315(1):171-196.
PMID: 36722494 PMC: 10771342. DOI: 10.1111/imr.13190.
Lisovska N Oncol Lett. 2022; 23(6):190.
PMID: 35527781 PMC: 9073577. DOI: 10.3892/ol.2022.13310.